ダーマルフィラー(皮膚充填剤)の中東市場規模・シェア・開発・成長・需要予測

◆英語タイトル:Middle East Dermal Fillers Market by Type (Hyaluronic Acid-Based, Hydroxylapatite-Based, Synthetic Polymer-Based, Collagen-Based), by Application (Facial Line Correction, Face-Lift, Lip Treatment), by End User (Dermatology Clinics, Hospitals), by Geography (Saudi Arabia, U.A.E) -Market Size, Share, Development, Growth, and Demand Forecast, 2013-2023
◆商品コード:PSM804043
◆発行会社(リサーチ会社):P&S Market Research
◆発行日:2018年3月
◆ページ数:84
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:中東
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Group License(5名様閲覧用)USD3,250 ⇒換算¥357,500見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,750 ⇒換算¥852,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はP&S Market Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。P&S Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

The growth is mainly led by increasing prevalence of skin problems, growing aging population, increasing awareness about age related skin problems, thriving medical tourism industry, and increase in disposable income.
Insights on market segments

On the basis of the type of dermal fillers, the market is categorized into hyaluronic acid-based, hydroxylapatite-based, synthetic polymer-based, and collagen-based fillers. Till now, hyaluronic acid-based fillers have been accounting for the largest share in the dermal fillers market of the Middle East. It is also expected to be the fastest growing category during the forecast period. This can be mainly attributed to the ability of these tissue fillers to attract water molecules, which aids in hydration and increasing skin volume.

On the basis of application, the dermal fillers market in the Middle East has been segmented into facial line correction, face lift, lip treatment, and others. Facial line correction has been holding the largest share in the dermal fillers market, with an estimated revenue contribution of 45.6% in 2017. It is also expected to be the fastest growing category during the forecast period, due to increasing number of patients opting for this treatment.

Dermal fillers are used by various end users, such as dermatology clinics, hospitals, and others. Among these, dermatology clinics is the largest end user of tissue fillers in the Middle East and it is also expected to be the fastest growing end user category during the forecast period, owing to the presence of skilled professionals in these clinics for administering these fillers.

Saudi Arabia to remain the largest market in the Middle East for dermal fillers

Historically, in terms of size, Saudi Arabia has been leading the dermal fillers industry in the Middle East. This can be attributed to growing aging population, increasing demand for cosmetic procedures, and availability of skilled practitioners for dermal filler procedures in the country. According to UNDESA, the proportion of people in Saudi Arabia aged 60 years and above is predicted to be 25% of the total population of 40 million by the end of 2050, leading to the growth of the market in Saudi Arabia, and thereby, maintaining its leading position in the Middle East.

Key players launching hyaluronic acid-based fillers in the Middle East market

In the Middle East, key players in the dermal fillers industry are launching tissue fillers based on hyaluronic acid to gain a larger market share. For instance, in March 2018, Galderma S.A. in collaboration with AMCo Group and Medica Group, launched two Restylane hyaluronic acid fillers in Saudi Arabia, namely Restylane Refyne and Restylane Defyne. Some of the other major players operating in the dermal fillers market include Allergan plc, Merz Pharma GmbH & Co. KGaA, Sinclair Pharma plc, and Teoxane Laboratories.

【レポートの目次】

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Type

1.3.2 Market Segmentation by Application

1.3.3 Market Segmentation by End User

1.3.4 Market Segmentation by Geography

1.3.5 Analysis Period

1.3.6 Market Data Reporting Unit

1.3.6.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By country

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Type

4.1.1.1 Hyaluronic acid-based dermal fillers

4.1.1.2 Hydroxylapatite-based dermal fillers

4.1.1.3 Synthetic polymer-based

4.1.1.4 Collagen-based dermal fillers

4.1.2 By Application

4.1.2.1 Facial line correction

4.1.2.2 Face-lift

4.1.2.3 Lip treatment

4.1.2.4 Others

4.1.3 By End User

4.1.3.1 Dermatology clinics

4.1.3.2 Hospitals

4.1.3.3 Others

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Increasing demand for lip augmentation procedures

4.2.1.2 Shift in the preference for minimally invasive cosmetic surgeries

4.2.1.3 Growing product launches in the Middle East

4.2.2 Drivers

4.2.2.1 Increasing prevalence of skin problems

4.2.2.2 Growing aging population

4.2.2.3 Increasing awareness about age related skin problems

4.2.2.4 Thriving medical tourism industry

4.2.2.5 Increase in disposable income

4.2.2.6 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 Stringent regulatory norms

4.2.3.2 Fear of social unacceptance or embarrassment

4.2.3.3 Side effects associated with dermal fillers

4.2.3.4 Impact analysis of restraints on market forecast

4.3 Porter’s Five Forces Analysis

4.3.1 Bargaining Power of Buyers

4.3.2 Bargaining Power of Suppliers

4.3.3 Threat of New Entrants

4.3.4 Intensity of Rivalry

4.3.5 Threat of Substitutes

Chapter 5. Middle East Market Size and Forecast

5.1 By Type

5.2 By Application

5.3 By End User

5.4 By Country

Chapter 6. Saudi Arabia Market Size and Forecast

6.1 By Type

6.2 By Application

6.3 By End User

Chapter 7. U.A.E. Market Size and Forecast

7.1 By Type

7.2 By Application

7.3 By End User

Chapter 8. Rest of Middle East Market Size and Forecast

8.1 By Type

8.2 By Application

8.3 By End User

Chapter 9. Competitive Landscape

9.1 Product Benchmarking of Key Players

9.2 Strategic Developments of Key Players

Chapter 10. Company Profiles

10.1 Allergan plc

10.1.1 Business Overview

10.1.2 Product and Service Offerings

10.1.3 Key Financial Summary

10.1.4 Strategic Growth Plans

10.2 Galderma S.A.

10.2.1 Business Overview

10.2.2 Product and Service Offerings

10.3 Merz Pharma GmbH & Co. KGaA

10.3.1 Business Overview

10.3.2 Product and Service Offerings

10.3.3 Key Financial Summary

10.3.4 Strategic Growth Plans

10.4 Sinclair Pharma plc

10.4.1 Business Overview

10.4.2 Product and Service Offerings

10.4.3 Key Financial Summary

10.4.4 Strategic Growth Plans

10.5 Teoxane Laboratories

10.5.1 Business Overview

10.5.2 Product and Service Offerings

Chapter 11. Appendix

11.1 Abbreviations

11.2 Sources and References

11.3 Related Reports

LIST OF TABLES

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 MIDDLE EAST DERMAL FILLERS MARKET, BY TYPE, $’000 (2013–2017)

TABLE 5 MIDDLE EAST DERMAL FILLERS MARKET, BY TYPE, $’000 (2018–2023)

TABLE 6 MIDDLE EAST DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2013–2017)

TABLE 7 MIDDLE EAST DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2018–2023)

TABLE 8 MIDDLE EAST DERMAL FILLERS MARKET, BY END USER, $’000 (2013–2017)

TABLE 9 MIDDLE EAST DERMAL FILLERS MARKET, BY END USER, $’000 (2018–2023)

TABLE 10 MIDDLE EAST DERMAL FILLERS MARKET, BY COUNTRY, $’000 (2013–2017)

TABLE 11 MIDDLE EAST DERMAL FILLERS MARKET, BY COUNTRY, $’000 (2018–2023)

TABLE 12 SAUDI ARABIA DERMAL FILLERS MARKET, BY TYPE, $’000 (2013–2017)

TABLE 13 SAUDI ARABIA DERMAL FILLERS MARKET, BY TYPE, $’000 (2018–2023)

TABLE 14 SAUDI ARABIA DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2013–2017)

TABLE 15 SAUDI ARABIA DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2018–2023)

TABLE 16 SAUDI ARABIA DERMAL FILLERS MARKET, BY END USER, $’000 (2013–2017)

TABLE 17 SAUDI ARABIA DERMAL FILLERS MARKET, BY END USER, $’000 (2018–2023)

TABLE 18 U.A.E. DERMAL FILLERS MARKET, BY TYPE, $’000 (2013–2017)

TABLE 19 U.A.E. DERMAL FILLERS MARKET, BY TYPE, $’000 (2018–2023)

TABLE 20 U.A.E. DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2013–2017)

TABLE 21 U.A.E. DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2018–2023)

TABLE 22 U.A.E. DERMAL FILLERS MARKET, BY END USER, $’000 (2013–2017)

TABLE 23 U.A.E. DERMAL FILLERS MARKET, BY END USER, $’000 (2018–2023)

TABLE 24 REST OF MIDDLE EAST DERMAL FILLERS MARKET, BY TYPE, $’000 (2013–2017)

TABLE 25 REST OF MIDDLE EAST DERMAL FILLERS MARKET, BY TYPE, $’000 (2018–2023)

TABLE 26 REST OF MIDDLE EAST DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2013–2017)

TABLE 27 REST OF MIDDLE EAST DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2018–2023)

TABLE 28 REST OF MIDDLE EAST DERMAL FILLERS MARKET, BY END USER, $’000 (2013–2017)

TABLE 29 REST OF MIDDLE EAST DERMAL FILLERS MARKET, BY END USER, $’000 (2018–2023)

TABLE 30 ALLERGAN PLC – AT A GLANCE

TABLE 31 ALLERGAN PLC – KEY FINANCIAL SUMMARY

TABLE 32 GALDERMA S.A. – AT A GLANCE

TABLE 33 MERZ PHARMA GMBH & CO. KGAA – AT A GLANCE

TABLE 34 MERZ PHARMA GMBH & CO. KGAA – KEY FINANCIAL SUMMARY

TABLE 35 SINCLAIR PHARMA PLC – AT A GLANCE

TABLE 36 SINCLAIR PHARMA PLC – KEY FINANCIAL SUMMARY

TABLE 37 TEOXANE LABORATORIES – AT A GLANCE

LIST OF FIGURES

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 GEOGRAPHICAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY COUNTRY

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH

FIG 8 MIDDLE EAST DERMAL FILLERS MARKET SUMMARY

FIG 9 PORTER’S FIVE FORCES ANALYSIS

FIG 10 SNAPSHOT OF MIDDLE EAST DERMAL FILLERS MARKET

FIG 11 MIDDLE EAST DERMAL FILLERS MARKET, BY TYPE, $’000 (2013–2023)

FIG 12 MIDDLE EAST DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2013–2023)

FIG 13 MIDDLE EAST DERMAL FILLERS MARKET, BY END USER, $’000 (2013–2023)

FIG 14 MAJOR MARKETS FOR DERMAL FILLERS IN MIDDLE EAST

FIG 15 SAUDI ARABIA DERMAL FILLERS MARKET SNAPSHOT

FIG 16 SAUDI ARABIA DERMAL FILLERS MARKET, BY TYPE, $’000 (2013–2023)

FIG 17 SAUDI ARABIA DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2013–2023)

FIG 18 SAUDI ARABIA DERMAL FILLERS MARKET, BY END USER, $’000 (2013–2023)

FIG 19 U.A.E. DERMAL FILLERS MARKET SNAPSHOT

FIG 20 U.A.E. DERMAL FILLERS MARKET, BY TYPE, $’000 (2013–2023)

FIG 21 U.A.E. DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2013–2023)

FIG 22 U.A.E. DERMAL FILLERS MARKET, BY END USER, $’000 (2013–2023)

FIG 23 REST OF MIDDLE EAST DERMAL FILLERS MARKET SNAPSHOT

FIG 24 REST OF MIDDLE EAST DERMAL FILLERS MARKET, BY TYPE, $’000 (2013–2023)

FIG 25 REST OF MIDDLE EAST DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2013–2023)

FIG 26 REST OF MIDDLE EAST DERMAL FILLERS MARKET, BY END USER, $’000 (2013–2023)

FIG 27 PRODUCT BENCHMARKING OF KEY PLAYERS

FIG 28 ALLERGAN PLC – REVENUE SPLIT BY SEGMENT (2017)

FIG 29 MERZ PHARMA GMBH & CO. KGAA – REVENUE SPLIT BY GEOGRAPHY (2017)

FIG 30 SINCLAIR PHARMA PLC – REVENUE SPLIT BY GEOGRAPHY (2016)



【レポートのキーワード】

ダーマルフィラー(皮膚充填剤)

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ダーマルフィラー(皮膚充填剤)の中東市場規模・シェア・開発・成長・需要予測(Middle East Dermal Fillers Market by Type (Hyaluronic Acid-Based, Hydroxylapatite-Based, Synthetic Polymer-Based, Collagen-Based), by Application (Facial Line Correction, Face-Lift, Lip Treatment), by End User (Dermatology Clinics, Hospitals), by Geography (Saudi Arabia, U.A.E) -Market Size, Share, Development, Growth, and Demand Forecast, 2013-2023)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆